Skip to content
10-Q

Quarterly Report

CARDIOVASCULAR SYSTEMS, INC.

0001180145-23-000016

← back to feed
Filed
Feb 9, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2023 · Feb 7, 2023 41.96M sh
Shares Diluted Q2 2023 · Dec 31, 2022 39.66M sh
Shares Diluted Q2 2023 · Dec 31, 2022 39.64M sh
Shares Diluted Q2 2023 · Dec 31, 2021 39.2M sh
Shares Diluted Q2 2023 · Dec 31, 2021 39.14M sh
Capex Q2 2023 · Dec 31, 2022 $2.73M
Capex Q2 2023 · Dec 31, 2021 $2.43M
Operating Cash Flow Q2 2023 · Dec 31, 2022 −$17.2M
Operating Cash Flow Q2 2023 · Dec 31, 2021 −$12.32M
Cash And Equivalents Q2 2023 · Dec 31, 2022 $59.84M
Cash And Equivalents Q2 2023 · Jun 30, 2022 $66.42M
Stockholders Equity Q2 2023 · Dec 31, 2022 $239.39M
Stockholders Equity Q2 2023 · Sep 30, 2022 $242.15M
Stockholders Equity Q2 2023 · Jun 30, 2022 $249.48M
Stockholders Equity Q2 2023 · Dec 31, 2021 $259.53M
Stockholders Equity Q2 2023 · Sep 30, 2021 $263.19M
Stockholders Equity Q2 2023 · Jun 30, 2021 $270.96M
Current Liabilities Q2 2023 · Dec 31, 2022 $36.76M
Current Liabilities Q2 2023 · Jun 30, 2022 $39.95M
Total Liabilities Q2 2023 · Dec 31, 2022 $72.12M
Total Liabilities Q2 2023 · Jun 30, 2022 $73.2M
Current Assets Q2 2023 · Dec 31, 2022 $221.96M
Current Assets Q2 2023 · Jun 30, 2022 $241.85M
Total Assets Q2 2023 · Dec 31, 2022 $311.51M
Total Assets Q2 2023 · Jun 30, 2022 $322.68M
Eps Diluted Q2 2023 · Dec 31, 2022 −$0.20
Eps Diluted Q2 2023 · Dec 31, 2022 −$0.47
Eps Diluted Q2 2023 · Dec 31, 2021 −$0.23
Eps Diluted Q2 2023 · Dec 31, 2021 −$0.45
Eps Basic Q2 2023 · Dec 31, 2022 −$0.20
Eps Basic Q2 2023 · Dec 31, 2022 −$0.47
Eps Basic Q2 2023 · Dec 31, 2021 −$0.23
Eps Basic Q2 2023 · Dec 31, 2021 −$0.45
Sga Expense Q2 2023 · Dec 31, 2022 $41.64M
Sga Expense Q2 2023 · Dec 31, 2022 $86.12M
Sga Expense Q2 2023 · Dec 31, 2021 $40.4M
Sga Expense Q2 2023 · Dec 31, 2021 $82.25M
Rd Expense Q2 2023 · Dec 31, 2022 $9.53M
Rd Expense Q2 2023 · Dec 31, 2022 $18.59M
Rd Expense Q2 2023 · Dec 31, 2021 $8.87M
Rd Expense Q2 2023 · Dec 31, 2021 $18.9M
Net Income Q2 2023 · Dec 31, 2022 −$7.89M
Net Income Q2 2023 · Dec 31, 2022 −$18.52M
Net Income Q2 2023 · Sep 30, 2022 −$10.63M
Net Income Q2 2023 · Dec 31, 2021 −$8.97M
Net Income Q2 2023 · Dec 31, 2021 −$17.59M
Net Income Q2 2023 · Sep 30, 2021 −$8.62M
Operating Income Q2 2023 · Dec 31, 2022 −$8.53M
Operating Income Q2 2023 · Dec 31, 2022 −$19.43M
Operating Income Q2 2023 · Dec 31, 2021 −$8.56M
Operating Income Q2 2023 · Dec 31, 2021 −$16.67M
Gross Profit Q2 2023 · Dec 31, 2022 $42.99M
Gross Profit Q2 2023 · Dec 31, 2022 $85.97M
Gross Profit Q2 2023 · Dec 31, 2021 $41.06M
Gross Profit Q2 2023 · Dec 31, 2021 $85.12M
Cost Of Revenue Q2 2023 · Dec 31, 2022 $18.46M
Cost Of Revenue Q2 2023 · Dec 31, 2022 $35.16M
Cost Of Revenue Q2 2023 · Dec 31, 2021 $18.07M
Cost Of Revenue Q2 2023 · Dec 31, 2021 $32.38M
Revenue Q2 2023 · Dec 31, 2022 $61.45M
Revenue Q2 2023 · Dec 31, 2022 $121.13M
Revenue Q2 2023 · Dec 31, 2021 $59.14M
Revenue Q2 2023 · Dec 31, 2021 $117.51M